While signaling through ACE2 upon viral entry remains poorly defined, ACE2 expression and corresponding intracellular signaling may be downregulated, leading to increased vascular permeability and a prothrombotic phenotype in COVID-19 cases; a pathology that is exacerbated by certain comorbidities such as heart diseases [23,27,28]. The gene discussed is ACE2; the disease is COVID-19.